Suppository Selection for Adult Patients
For constipation use bisacodyl or glycerin suppositories when digital rectal exam identifies a full rectum; for analgesia/anti-inflammatory use diclofenac or indomethacin suppositories; for nausea/vomiting use prochlorperazine suppositories; and for local rectal anti-inflammatory therapy use mesalazine suppositories.
Constipation Management
When digital rectal examination reveals a full rectum or fecal impaction, suppositories are first-line therapy 1. The ESMO guidelines specifically recommend:
- Bisacodyl suppositories: Promote intestinal motility by drawing water into the intestinal lumen. Work within 15-60 minutes. May cause abdominal cramping 1
- Glycerin suppositories: Provide local rectal stimulation and lubrication. Particularly useful for mild constipation or when stimulant effects are undesired 1
Critical caveat: Avoid suppositories in neutropenic patients (WBC <0.5 cells/μL), thrombocytopenia, recent colorectal surgery, recent pelvic radiotherapy, or severe colitis 1.
Analgesia and Anti-Inflammatory Effect
Diclofenac suppositories (100mg) are highly effective for systemic analgesia, particularly for perineal pain where they reduced pain to mild levels in 56% of patients within 24 hours 2.
For chronic pain management:
- Opioid suppositories (morphine, hydromorphone, oxycodone) provide systemic analgesia when oral route is unavailable 3, 4
- Sustained-release formulations offer once or twice daily dosing with steady drug concentrations 3
- Rectal bioavailability is generally comparable to oral administration, though absorption can be variable with conventional fatty-based suppositories 3
NSAIDs via suppository (diclofenac, indomethacin) are simple, effective, and well-tolerated for both acute and chronic pain 2, 4.
Nausea and Vomiting
Prochlorperazine suppositories (25mg) are the standard rectal antiemetic when oral or IV routes are unavailable 4. Alternative options include:
- Promethazine suppositories
- Trimethobenzamide suppositories
The rectal route is particularly valuable in palliative care when patients cannot tolerate oral medications due to severe nausea 4. While newer guidelines discuss PONV management 5, they focus primarily on IV formulations rather than rectal routes.
Local Rectal Anti-Inflammatory Therapy
Mesalazine (5-aminosalicylic acid) suppositories are the treatment of choice for distal ulcerative proctitis, achieving:
- 85% healing rate within 4 weeks
- Nearly 100% healing by 10 weeks
- Coverage of the distal 20cm of rectum 6
Dosing strategy:
- Acute treatment: 500-1000mg daily or divided doses
- Maintenance: 500mg every other night to 1000mg daily 6
These suppositories are safe, well-tolerated, and demonstrate superior patient compliance compared to oral alternatives for distal disease 6. They also show efficacy in rectal Crohn's disease, though response is slower and less complete 6.
Important consideration: Mesalazine suppositories work best for disease limited to the distal rectum; proximal disease requires enemas or oral formulations 6.